Literature DB >> 15937090

TNFalpha and IL10 SNPs act together to predict disease behaviour in Crohn's disease.

E V Fowler, R Eri, G Hume, S Johnstone, N Pandeya, D Lincoln, D Templeton, G L Radford-Smith.   

Abstract

BACKGROUND: The cytokines tumour necrosis factor (TNF)alpha and interleukin (IL)10 have been implicated in the pathogenesis of Crohn's disease (CD), with increased concentrations reported in patients with active disease. However, limited data exist on their effects on disease phenotype in the same population. Certain single nucleotide polymorphisms (SNPs) within the promoter region of the IL10 (-1082G/A, -592C/A) and TNFalpha (-308G/A, -857C/T) genes have been associated with altered levels of circulating IL10 and TNFalpha.
METHODS: We conducted an Australian based case-control study (304 CD patients; 231 healthy controls) of these four SNPs. Further investigation of two SNPs was conducted using a logistic regression analysis.
RESULTS: We identified a possible association of both IL10 SNPs and TNFalpha-857 with CD. Further investigation of a relationship with disease severity showed a significant association of higher producing IL10-1082G and TNFalpha-857C alleles with stricturing behaviour, which was strongest when these alleles were combined and persisted after multivariate analysis (p = 0.007; odds ratio (OR) 2.37, 95% CI 1.26 to 4.43). In addition, the TNFalpha-857CC genotype was independently associated with familial CD (p = 0.03; OR 3.12; 95% CI 1.15 to 8.46).
CONCLUSION: These two SNPs may help to predict disease behaviour in CD patients, which may be clinically useful in shaping treatment of the disease at an earlier stage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937090      PMCID: PMC1736076          DOI: 10.1136/jmg.2004.027425

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  18 in total

1.  A meta-analysis on the association between three promoter variants of TNF-α and Crohn's disease.

Authors:  Cui Xie; Xiao Feng Liu; Mao Sheng Yang
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

2.  Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk.

Authors:  Lynnette R Ferguson; Claudia Huebner; Ivonne Petermann; Richard B Gearry; Murray L Barclay; Pieter Demmers; Alan McCulloch; Dug Yeo Han
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

3.  Angiotensinogen and transforming growth factor beta1: novel genes in the pathogenesis of Crohn's disease.

Authors:  G E Hume; E V Fowler; D Lincoln; R Eri; D Templeton; T H Florin; J A Cavanaugh; G L Radford-Smith
Journal:  J Med Genet       Date:  2006-10       Impact factor: 6.318

Review 4.  Immunogenetic biomarkers in inflammatory bowel diseases: role of the IBD3 region.

Authors:  Manuel Muro; Ruth López-Hernández; Anna Mrowiec
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

5.  Association of the IL-10 polymorphisms and periodontitis: a meta-analysis.

Authors:  C M Albuquerque; A J Cortinhas; F J Morinha; J C Leitão; C A Viegas; E M Bastos
Journal:  Mol Biol Rep       Date:  2012-07-05       Impact factor: 2.316

6.  Relationship between the polymorphism of tumor necrosis factor-α-308 G>A and susceptibility to inflammatory bowel diseases and colorectal cancer: a meta-analysis.

Authors:  Wang Fan; Wang Maoqing; Chen Wangyang; Hu Fulan; Li Dandan; Ren Jiaojiao; Dong Xinshu; Cui Binbin; Zhao Yashuang
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

Review 7.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

8.  The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study.

Authors:  Vibeke Andersen; Anja Ernst; Jane Christensen; Mette Østergaard; Bent A Jacobsen; Anne Tjønneland; Henrik B Krarup; Ulla Vogel
Journal:  BMC Med Genet       Date:  2010-05-28       Impact factor: 2.103

Review 9.  Why interleukin-10 supplementation does not work in Crohn's disease patients.

Authors:  Gareth J Marlow; Dominique van Gent; Lynnette R Ferguson
Journal:  World J Gastroenterol       Date:  2013-07-07       Impact factor: 5.742

10.  Clinical relevance of the interleukin 10 promoter polymorphisms in Chinese Han patients with major trauma: genetic association studies.

Authors:  Ling Zeng; Wei Gu; Kehong Chen; Dongpo Jiang; Lianyang Zhang; Dingyuan Du; Ping Hu; Qing Liu; Suna Huang; Jianxin Jiang
Journal:  Crit Care       Date:  2009-11-26       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.